Jvion Logo

Future Oncology Study: Augmented Intelligence to Predict 30-day Mortality in Patients with Cancer

With more than 1.6 million Americans diagnosed with cancer each year, oncology providers are turning to AI-powered prescriptive insights to deliver better care.

Read the Future Oncology Study

Download Now

In a recent study published by Future Oncology, Cardinal Health Speciality Solutions, Jvion and Northwest Medical Specialties report that Jvion's clinical AI accurately predicts short-term mortality risk among patients with cancer and guides the appropriate use of interventions and palliative care services.

By 2023

2.3 million people will be newly diagnosed with cancer in the U.S.1

By 2030

the number of cancer survivors is projected to increase by 31.4%, to 22.2 million2

1 IOM (Institute of Medicine). 2013. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: The National Academies Press.
2 National Cancer Institute Division of Cancer Control & Population Sciences. 2020.

Learn More About Navista™: